FDA Approves Hepzato Kit for Liver-Directed Treatment of Metastatic Uveal Melanoma
Melphalan/hepatic delivery system (Hepzato Kit; Delcath Systems Inc) is currently the only liver-directed therapy approved by the FDA for the treatment of netastatic uveal melanoma and percutaneous hepatic perfusion.